A raft of potentially therapeutic pharmaceuticals got left on the shelf in the backlash against the 1960s recreational drug explosion. Researchers are raising their own consciousness about which psychedelics might have real value.
MDMA holds promise as part of a therapy that helps post-traumatic stress patients confront and extinguish their fears. But ecstasy's recreational reputation has slowed research.